Evidence map›Paper›PMID 35312376›Full record

Trial reportThe British journal of radiology2022

Preoperative prediction of KRAS mutation status in colorectal cancer using a CT-based radiomics nomogram.

Ting Xue, Hui Peng, Qiaoling Chen, Manman Li, Shaofeng Duan, Feng Feng

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting XueDepartment of Radiology, Nantong University, Nantong, Jiangsu, PR China.
Hui PengDepartment of Radiology, Nantong University, Nantong, Jiangsu, PR China.
Qiaoling ChenDepartment of Radiology, Nantong University, Nantong, Jiangsu, PR China.
Manman LiDepartment of Radiology, Nantong University, Nantong, Jiangsu, PR China.
Shaofeng DuanGE Healthcare China, Shanghai, China.
Feng FengDepartment of Radiology, Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu, PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to develop a model to predict KRAS mutations in colorectal cancer according to radiomic signatures based on CT and clinical risk factors.

methodsThis retrospective study included 172 patients with colorectal cancer. All patients were randomized at a 7:3 ratio into a training cohort (

results1018 radiomics features were extracted from single-slice and full-volume ROIs. Eight features were retained to construct 2D (two-dimensional, 2D) radiomics model. Similarly, eight features were retained to construct 3D (three-dimensional, 3D) radiomics model. The area under the curve (AUC) values of the test cohort were 0.75 and 0.84, respectively. Delong test showed that the integrated nomogram (AUC = 0.92 in the test cohort) had better clinical predictive efficiency than 2D radiomics (

conclusionThe 2D and 3D radiomics models can both predict KRAS mutations. And, the integrated nomogram can be better applied to predict KRAS mutation status in colorectal cancer. ADVANCES IN KNOWLEDGE: CT-based radiomics showed satisfactory diagnostic significance for the KRAS status in colorectal cancer, the clinical-combined model may be applied in the individual pre-operative prediction of KRAS mutation.

Indexed as

Colorectal NeoplasmsNomogramsHumansMutationProto-Oncogene Proteins p21(ras)Retrospective StudiesTomography, X-Ray ComputedKRAS protein, humanProto-Oncogene Proteins p21(ras)

Identifiers

PMID35312376
PMCPMC10996413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.